Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 8
1965 4
1966 19
1967 29
1968 36
1969 106
1970 171
1971 558
1972 627
1973 725
1974 700
1975 878
1976 895
1977 928
1978 1024
1979 976
1980 691
1981 710
1982 697
1983 703
1984 868
1985 830
1986 797
1987 1245
1988 1137
1989 1328
1990 1311
1991 1415
1992 1503
1993 1429
1994 1722
1995 1602
1996 1632
1997 1654
1998 1726
1999 1647
2000 1692
2001 1733
2002 1758
2003 1812
2004 1867
2005 2218
2006 2050
2007 2061
2008 2211
2009 2407
2010 2544
2011 2625
2012 2599
2013 2997
2014 3101
2015 3329
2016 3439
2017 3568
2018 3742
2019 3893
2020 4974
2021 5619
2022 5177
2023 4851
2024 1809

Text availability

Article attribute

Article type

Publication date

Search Results

98,909 results

Results by year

Filters applied: . Clear all
Page 1
Immunosuppression in liver transplant.
Di Maira T, Little EC, Berenguer M. Di Maira T, et al. Best Pract Res Clin Gastroenterol. 2020 Jun-Aug;46-47:101681. doi: 10.1016/j.bpg.2020.101681. Epub 2020 Sep 11. Best Pract Res Clin Gastroenterol. 2020. PMID: 33158467 Review.
The increasing potency of immunosuppression (IS) agents resulted in significantly decreased rates of steroid resistant rejection and rejection related graft loss in liver transplantation (LT). ...The main causes of mortality late after liver transplant are associated with …
The increasing potency of immunosuppression (IS) agents resulted in significantly decreased rates of steroid resistant rejection and …
Immunosuppression in Lung Transplantation.
Nelson J, Kincaide E, Schulte J, Hall R, Levine DJ. Nelson J, et al. Handb Exp Pharmacol. 2022;272:139-164. doi: 10.1007/164_2021_548. Handb Exp Pharmacol. 2022. PMID: 34796380 Review.
Immunosuppression in lung transplantation is an area devoid of robust clinical data. This chapter will review the history of immunosuppression in lung transplantation. Additionally, it will evaluate the three classes of induction, maintenance, and rescue immunosu …
Immunosuppression in lung transplantation is an area devoid of robust clinical data. This chapter will review the history of immun …
Immunosuppressive Agents and Infectious Risk in Transplantation: Managing the "Net State of Immunosuppression".
Roberts MB, Fishman JA. Roberts MB, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1302-e1317. doi: 10.1093/cid/ciaa1189. Clin Infect Dis. 2021. PMID: 32803228 Free PMC article. Review.
Successful solid organ transplantation reflects meticulous attention to the details of immunosuppression, balancing risks for graft rejection against risks for infection. ...These data provide a conceptual framework for the management of immunosuppression during inf …
Successful solid organ transplantation reflects meticulous attention to the details of immunosuppression, balancing risks for graft r …
Immunosuppression after uterus transplantation.
Martin F, Tullius SG. Martin F, et al. Curr Opin Organ Transplant. 2021 Dec 1;26(6):627-633. doi: 10.1097/MOT.0000000000000925. Curr Opin Organ Transplant. 2021. PMID: 34581290 Review.
The procedure represents the only therapy for women with absolute uterine factor infertility to give birth to a biological baby. Immunosuppression after UTx needs to carefully balance effects with the healthy mother and baby. ...RECENT FINDINGS: Clinical UTx-trials have be …
The procedure represents the only therapy for women with absolute uterine factor infertility to give birth to a biological baby. Immunosu …
Immunosuppression in gastroenterology and hepatology.
Neuberger J. Neuberger J. Best Pract Res Clin Gastroenterol. 2021 Oct-Dec;54-55:101758. doi: 10.1016/j.bpg.2021.101758. Epub 2021 Jun 17. Best Pract Res Clin Gastroenterol. 2021. PMID: 34874842 Review.
In recent years, the clinician has a more diverse approach to immunosuppression. Now, for many conditions, such as solid organ transplantation or treatment of some autoimmune diseases, the consequences of immunosuppression becomes a greater risk than organ failure f …
In recent years, the clinician has a more diverse approach to immunosuppression. Now, for many conditions, such as solid organ transp …
Immunosuppression in HIV-positive kidney transplant recipients.
Sorohan BM, Ismail G, Leca N. Sorohan BM, et al. Curr Opin Organ Transplant. 2023 Aug 1;28(4):279-289. doi: 10.1097/MOT.0000000000001076. Epub 2023 May 23. Curr Opin Organ Transplant. 2023. PMID: 37219235 Review.
RECENT FINDINGS: Certain studies find higher rates of rejection, which raises the need to critically assess the approach to immunosuppression management in HIV-positive KTR. Induction immunosuppression is guided by transplant center-level preference rather than by t …
RECENT FINDINGS: Certain studies find higher rates of rejection, which raises the need to critically assess the approach to immunosuppres …
Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022.
Kant S, Kronbichler A, Geetha D. Kant S, et al. Am J Kidney Dis. 2022 Sep;80(3):393-405. doi: 10.1053/j.ajkd.2021.12.011. Epub 2022 Apr 16. Am J Kidney Dis. 2022. PMID: 35440396 Review.
The management of immunosuppression utilized in glomerular diseases requires highly nuanced care. ...This involves being cognizant of the various classes of immunosuppression, which includes alkylating agents, antimetabolites, calcineurin inhibitors, anti-CD20 thera …
The management of immunosuppression utilized in glomerular diseases requires highly nuanced care. ...This involves being cognizant of …
Immunosuppression and Kidney Transplantation.
Kamal J, Doyle A. Kamal J, et al. Handb Exp Pharmacol. 2022;272:165-179. doi: 10.1007/164_2021_546. Handb Exp Pharmacol. 2022. PMID: 34697664 Review.
Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successful allotransplantation. ...
Immunosuppression is complex, fraught with on-target and off-target adverse effects, and hard to get right but is the key to successf …
Immunosuppression for the Uveitides.
Jabs DA. Jabs DA. Ophthalmology. 2018 Feb;125(2):193-202. doi: 10.1016/j.ophtha.2017.08.007. Epub 2017 Sep 20. Ophthalmology. 2018. PMID: 28942074 Free PMC article. Review.
Nonalkylating-agent immunosuppression has a low rate of sustained, drug-free remissions, <10%/year. Nonalkylating-agent immunosuppression for >3 years with control of the inflammation for >2 years is associated with a decreased risk of relapse after discont …
Nonalkylating-agent immunosuppression has a low rate of sustained, drug-free remissions, <10%/year. Nonalkylating-agent immunos …
Immunosuppression Monitoring-What Clinician Needs to Know?
Wadhawan M, Gupta C. Wadhawan M, et al. J Clin Exp Hepatol. 2023 Jul-Aug;13(4):691-697. doi: 10.1016/j.jceh.2023.01.003. Epub 2023 Jan 9. J Clin Exp Hepatol. 2023. PMID: 37440936 Review.
There are significant individual variations in response and side effect profile. Also, the level of immunosuppression varies with the underlying liver disease like autoimmune disease requires higher immunosuppression. Thus, monitoring the adequate immunosuppressi …
There are significant individual variations in response and side effect profile. Also, the level of immunosuppression varies with the …
98,909 results
You have reached the last available page of results. Please see the User Guide for more information.